A Clinical Investigation of Recovery Following Hip Resurfacing or Total Hip Arthroplasty
NCT ID: NCT00585988
Last Updated: 2017-06-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2007-06-30
2010-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study on M2a Magnum Total Hip Arthroplasty
NCT01010763
An MRI Investigation of Soft Tissues in Total Hip Arthroplasty
NCT01750606
Dual Energy X-ray Absorptiometry (DXA) Comparison Hip Resurfacing Versus Total Hip Arthroplasty (THA)
NCT01359527
A Clinical Investigation of the C2a-Taper™ Acetabular System
NCT00578851
Outcomes of Robotic Total Hip Arthroplasty
NCT01672320
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Hip Resurfacing System
This arm will utilize a hip resurfacing system.
2
M2a-Magnum™ Large Metal Articulation
This arm will utilize the M2a-Magnum™ implant system.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hip Resurfacing System
This arm will utilize a hip resurfacing system.
M2a-Magnum™ Large Metal Articulation
This arm will utilize the M2a-Magnum™ implant system.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients with vestibular disorders
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Biomet Orthopedics, LLC
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
292-U-010
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.